News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Photo of Dr. Hagop Kantarjian from obroncology.com
Apr 20, 2024, 07:03

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Dasatinib and Venetoclax is safe and effective in newly diagnosed Chronic Myeloid Leukaemia in CP, but no better than single-agent Dasatinib, longer follow-up needed to evaluate impact on TFR.”

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Additional information.
Source: Hagop Kantarjian/X

 

cancer chronic myeloid leukaemia CML Dasatinib Hagop Kantarjian MD Anderson Cancer Center OncoDaily Oncology TFR The University of Texas venetoclax
Special Coverage
Voices
Sep 3, 2025, 08:25
Making Self-Checks a Habit Is So Important – Pink Hearts Cancer Support Foundation
Science
Sep 3, 2025, 08:23
Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs
Science
Sep 3, 2025, 08:11
Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML
Voices
Sep 3, 2025, 08:06
Douglas Flora: What it's Like to Be a Cancer Patient - Leaves, Branches, and Roots
Voices
Sep 3, 2025, 08:01
No Child Left Behind: Prioritizing Childhood Cancer in the Next EU Budget - AIEOP
Voices
Sep 3, 2025, 07:58
Anh Lam: Join us in Chicago for ASCO Quality Care Symposium
Insight
Sep 3, 2025, 07:55
Oncology Updates: August Edition from BG Lab
Science
Sep 3, 2025, 07:49
Alessandro Di Federico: Not All Oncogenes Are the Same
Career Updates
Sep 3, 2025, 07:48
Matthew Kurian: Registration is Open for Implications of HER2 Testing in Cancer Management Session
Voices
Sep 3, 2025, 07:37
Tyler Seibert: Rare but Tragic Outcomes After Radiation for Pelvic Cancers
Societies
Sep 3, 2025, 07:28
Free Childcare for Congress Delegates With Children Aged 1–12 - ESGO
Voices
Sep 3, 2025, 07:14
Eric Whitman: Register for Virtual Post-ASCO Conference on September 20